This material is provided by CHEPLAPHARM Schweiz GmbH, as part of the risk minimization plan for ACCUTANE. This material is not intended for promotional use.
Acne, ACCUTANE™ and You
The information on this site is intended to support the ACCUTANE education and counselling that you provide to your patients during office visits.
ACCUTANE™ (isotretinoin) is indicated for the treatment of:
- Severe Nodular and/or Inflammatory Acne
- Acne Conglobata
- Recalcitrant Acne
Because of significant side effects associated with its use, ACCUTANE should be reserved for patients where the conditions listed above are unresponsive to conventional first line therapies.
ACCUTANE should only be prescribed by physicians knowledgeable in the use of retinoids systemically, who understand the risk of teratogenicity in females of child bearing age and who are experienced in counselling young adults for whom ACCUTANE is generally indicated (see CONTRAINDICATIONS and WARNINGS AND PRECAUTIONS: Serious Warnings and Precautions and Special Populations, Pregnant Women).
A careful assessment of the patient’s mental state should be made, including whether or not they have a history of previous psychiatric illness (see WARNINGS AND PRECAUTIONS, Serious Warnings and Precautions, Psychiatric).
It is strongly recommended that each ACCUTANE prescription be limited to a one-month supply in order to encourage patients to return for follow-up to monitor side-effects. Prescriptions of ACCUTANE for women of childbearing potential should be limited to 30 days of treatment and continuation of treatment requires a new prescription.
Consult the product monograph by visiting the Health Canada website (French: www.canada.ca/fr/sante-canada.html) for contraindications, warnings, precautions, adverse reactions, interactions, dosing, and conditions of clinical use. The Product Monograph is also available by calling us at 1-888-XEDITON (933-4866)
.
The following assistance is available to physicians and Accutane patients:
- “Acne, ACCUTANE and You” patient booklet and AcneandU.ca website, which contain information for patients, including the PREGNANCY PREVENTION PROGRAM™, to support Canadian patient safety while on ACCUTANE
The following tools can be used to assist you when prescribing ACCUTANE:
© CHEPLAPHARM Schweiz GmbH. All Rights Reserved. AcneandU.ca is a service provided by CHEPLAPHARM Schweiz GmbH.
© CHEPLAPHARM Schweiz GmbH. All Rights Reserved. AcneandU.ca is a service provided by CHEPLAPHARM Schweiz GmbH.
This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report, please report adverse events to Health Canada directly by going to the Canada Vigilance Program website at https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html.
This material is provided by Cheplapharm Schweiz GmbH, as part of the risk minimization plan for ACCUTANE. This material is not intended for promotional use.